시장보고서
상품코드
1473057

세계의 조직학 및 세포학 시장 규모, 점유율 및 동향 분석 보고서 - 유형별, 제품별, 시험 유형별, 용도별, 최종 사용자별, 지역별 전망 및 예측(2024-2031년)

Global Histology and Cytology Market Size, Share & Trends Analysis Report By Type, By Product (Consumable & Reagents, and Instruments & Analysis Software System), By Test Type, By Application, By End User, By Regional Outlook and Forecast, 2024 - 2031

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 325 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

조직학 및 세포학 시장 규모는 예측 기간 동안 13.8%의 연평균 복합 성장률(CAGR)로 성장하여 2031년까지 438억 달러에 달할 것으로 예상됩니다.

또한, 지구상의 모든 국가에서 노인 인구가 위험할 정도로 빠르게 증가하고 있습니다. 노인 인구는 2050년까지 약 15억 명에 달할 것으로 예측됩니다. 2050년까지 노인 인구는 전 세계 인구의 16.0%를 차지할 것으로 예상됩니다. 따라서 고령화 인구 증가는 노화 관련 질병의 확산을 촉진하고 조직학 및 세포학 검사에 대한 수요를 촉진할 것입니다.

코로나19 팬데믹은 조직학 및 세포학 분야에 큰 영향을 미쳤으며, 도전과 기회를 동시에 가져왔습니다. 전 세계 의료 시스템이 전례 없는 부담에 직면한 가운데, 코로나19 환자 관리에 자원을 우선적으로 투입하기 위해 정기적인 조직학 및 세포학 검사를 포함한 많은 비응급 의료 절차가 연기되거나 축소되었습니다. 이러한 혼란으로 인해 암 검진 및 진단이 지연되어 환자 결과에 영향을 미치고 사례가 쌓일 수 있습니다. 따라서 전염병은 전반적으로 시장에 긍정적인 영향을 미쳤습니다.

그러나 조직학 및 세포학 실험실에서는 표본 처리, 염색, 이미징 및 분석을 위한 특수 장비, 시약 및 소모품이 필요합니다. 장비 구입 및 유지 보수에 드는 초기 비용과 시약 조달 및 품질 관리와 관련된 지속적인 비용이 전체 테스트 비용에 영향을 미칩니다. 따라서 높은 비용으로 인해 시장 발전이 어느 정도 제한될 수 있습니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장 요람

제3장 시장 개요

  • 서론
    • 개요
      • 시장 구성과 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 성장 촉진요인
    • 시장 기회
    • 시장 성장 억제요인
    • 시장이 해결해야 할 과제
  • Porter의 Five Forces 분석

제4장 세계 시장 : 시험 유형별

  • 세계의 세포학 시장 : 지역별
  • 세계의 조직학 시장 : 지역별

제5장 세계 시장 : 제품별

  • 세계의 소모품 및 시약 시장 : 지역별
  • 세계의 계측 기기 및 분석 소프트웨어 시스템 시장 : 지역별

제6장 세계 시장 : 시험 유형별

  • 세계의 현미경 시험 시장 : 지역별
  • 세계의 유세포 분석기 시장 : 지역별
  • 세계의 분자유전학적 방법 시장 : 지역별

제7장 세계 시장 : 용도별

  • 세계의 Drug Discovery·설계 시장 : 지역별
  • 세계의 임상 진단 시장 : 지역별
  • 세계의 학술 연구 시장 : 지역별

제8장 세계 시장 : 최종사용자별

  • 세계의 제약 기업 및 바이오테크놀러지 기업 시장 : 지역별
  • 세계의 진단실험실 시장 : 지역별
  • 세계의 CDMO 시장 : 지역별
  • 세계의 기타 시장 : 지역별

제9장 세계 시장 : 지역별

  • 북미
    • 북미 시장 : 국가별
      • 미국
      • 캐나다
      • 멕시코
      • 기타 북미
  • 유럽
    • 유럽 시장 : 국가별
      • 독일
      • 영국
      • 프랑스
      • 러시아
      • 스페인
      • 이탈리아
      • 기타 유럽
  • 아시아태평양
    • 아시아태평양 시장 : 국가별
      • 중국
      • 일본
      • 인도
      • 한국
      • 싱가포르
      • 말레이시아
      • 기타 아시아태평양
  • 라틴아메리카/중동 및 아프리카
    • 라틴아메리카/중동 및 아프리카 시장 : 국가별
      • 브라질
      • 아르헨티나
      • 아랍에미리트(UAE)
      • 사우디아라비아
      • 남아프리카공화국
      • 나이지리아
      • 기타 라틴아메리카/중동 및 아프리카

제10장 기업 개요

  • Merck KGaA
  • Becton, Dickinson, and Company
  • Hologic, Inc
  • Trivitron Healthcare Pvt Ltd.
  • Danaher Corporation
  • F Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc
  • Koninklijke Philips NV
  • Sysmex Corporation
  • Abbott Laboratories

제11장 조직학 및 세포학 시장을 위한 성공 필수 조건

LSH 24.05.21

The Global Histology and Cytology Market size is expected to reach $43.8 billion by 2031, rising at a market growth of 13.8% CAGR during the forecast period.

Histology and cytology services are in greater demand in the Asia-Pacific region because of the increasing incidence of cancer and the prevalence of chronic diseases. Thus, the Asia Pacific region acquired 25% revenue share in 2023. The Asia Pacific region represents a dynamic and rapidly growing market in histology and cytology, driven by increasing healthcare spending, rising prevalence of chronic diseases, and expanding access to diagnostic services.

Personalized medicine entails customizing medical interventions to accommodate the unique attributes of individual patients, including, but not limited to, their lifestyle, environment, and genetic composition. Thus, as personalized medicine continues, the demand for advanced histology and cytology tests that can provide detailed molecular information is expected to grow.

Additionally, the elderly population is increasing dangerously quickly in every nation on Earth. Its population is projected to reach approximately 1.5 billion people by 2050. Seniors are expected to make up 16.0% of the world's population by 2050.Therefore, the increasing aging population drives the demand for histological and cytological testing by fueling the prevalence of age-related diseases.

The COVID-19 pandemic profoundly impacted the field of histology and cytology, introducing both challenges and opportunities. With healthcare systems worldwide facing unprecedented strain, many non-urgent medical procedures, including routine histological and cytological examinations, were postponed or scaled back to prioritize resources for managing COVID-19 patients. This disruption led to delays in cancer screenings and diagnoses, potentially affecting patient outcomes and contributing to a backlog of cases. Thus, the pandemic had an overall positive impact on the market.

However, Histology and cytology laboratories require specialized equipment, reagents, and consumables for specimen processing, staining, imaging, and analysis. The upfront costs of purchasing and maintaining equipment and the ongoing expenses associated with reagent procurement and quality control contribute to the overall cost of testing. Hence, the high cost may limit the development of the market to some extent.

By Type of Examination Analysis

By type of examination, the market is bifurcated into cytology and histology. The cytology segment procured the maximum, 78.4% revenue share in the market in 2023. The segment is growing owing to the rising need for cytology services. As the population ages and grows, the incidence of cancer is also expected to increase, leading to a higher demand for cytology services.

By Product Analysis

Based on product, the market is characterized by instruments & analysis software system and consumable & reagents. The instruments & analysis software system segment garnered a significant 39.4% revenue share in the market in 2023. Instruments and analysis software systems are essential to the market, facilitating tissue and cellular specimens' processing, examination, and interpretation.

By Test Type Analysis

On the basis of test type, the market is classified into microscopy methods, flow cytometry, and molecular genetic methods. The microscopy methods segment acquired 54.3% revenue share in the market in 2023. Advancements in imaging technology, automation, and software integration offer enhanced histological and cytological analysis capabilities.

By Application Analysis

On the basis of application, the market is characterized by drug discovery & designing, clinical diagnostics, and academic research. The clinical diagnostics segment recorded a remarkable 38% revenue share in the market in 2023. Clinical diagnostics are pivotal in boosting the market by providing essential tools and techniques for disease diagnosis, patient management, and treatment optimization.

By End User Analysis

By end user, the market is fragmented into pharma & biotech companies, CDMO, diagnostic laboratories, and others. The pharma & biotech companies segment procured 39.1% revenue share in the market in 2023. Pharmaceutical and biotechnology companies significantly boost the market by contributing to drug discovery, development, and personalized medicine initiatives.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured 40% revenue share in market in 2023. With a robust network of diagnostic laboratories, academic institutions, and healthcare facilities, North America leads in adopting innovative technologies and practices within the field.

List of Key Companies Profiled

  • Merck KGaA
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Trivitron Healthcare Pvt. Ltd.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • Sysmex Corporation
  • Abbott Laboratories

Global Histology and Cytology Market Report Segmentation

By Type of Examination

  • Cytology
  • Histology

By Product

  • Consumable & Reagents
  • Instruments & Analysis Software System

By Test Type

  • Microscopy Methods
  • Flow Cytometry
  • Molecular Genetic Methods

By Application

  • Drug Discovery & Designing
  • Clinical Diagnostics
  • Academic Research

By End User

  • Pharma & Biotech Companies
  • Diagnostic Laboratories
  • CDMO
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Global Histology and Cytology Market, by Type of Examination
    • 1.4.2Global Histology and Cytology Market, by Product
    • 1.4.3Global Histology and Cytology Market, by Test Type
    • 1.4.4Global Histology and Cytology Market, by Application
    • 1.4.5Global Histology and Cytology Market, by End User
    • 1.4.6Global Histology and Cytology Market, by Geography
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Opportunities
    • 3.2.3Market Restraints
    • 3.2.4Market Challenges
  • 3.3Porter Five Forces Analysis

Chapter 4.Global Histology and Cytology Market by Type of Examination

  • 4.1Global Cytology Market by Region
  • 4.2Global Histology Market by Region

Chapter 5.Global Histology and Cytology Market by Product

  • 5.1Global Consumable & Reagents Market by Region
  • 5.2Global Instruments & Analysis Software System Market by Region

Chapter 6.Global Histology and Cytology Market by Test Type

  • 6.1Global Microscopy Methods Market by Region
  • 6.2Global Flow Cytometry Market by Region
  • 6.3Global Molecular Genetic Methods Market by Region

Chapter 7.Global Histology and Cytology Market by Application

  • 7.1Global Drug Discovery & Designing Market by Region
  • 7.2Global Clinical Diagnostics Market by Region
  • 7.3Global Academic Research Market by Region

Chapter 8.Global Histology and Cytology Market by End User

  • 8.1Global Pharma & Biotech Companies Market by Region
  • 8.2Global Diagnostic Laboratories Market by Region
  • 8.3Global CDMO Market by Region
  • 8.4Global Others Market by Region

Chapter 9.Global Histology and Cytology Market by Region

  • 9.1North America Histology and Cytology Market
    • 9.1.1North America Histology and Cytology Market by Type of Examination
      • 9.1.1.1North America Cytology Market by Region
      • 9.1.1.2North America Histology Market by Region
    • 9.1.2North America Histology and Cytology Market by Product
      • 9.1.2.1North America Consumable & Reagents Market by Country
      • 9.1.2.2North America Instruments & Analysis Software System Market by Country
    • 9.1.3North America Histology and Cytology Market by Test Type
      • 9.1.3.1North America Microscopy Methods Market by Country
      • 9.1.3.2North America Flow Cytometry Market by Country
      • 9.1.3.3North America Molecular Genetic Methods Market by Country
    • 9.1.4North America Histology and Cytology Market by Application
      • 9.1.4.1North America Drug Discovery & Designing Market by Country
      • 9.1.4.2North America Clinical Diagnostics Market by Country
      • 9.1.4.3North America Academic Research Market by Country
    • 9.1.5North America Histology and Cytology Market by End User
      • 9.1.5.1North America Pharma & Biotech Companies Market by Country
      • 9.1.5.2North America Diagnostic Laboratories Market by Country
      • 9.1.5.3North America CDMO Market by Country
      • 9.1.5.4North America Others Market by Country
    • 9.1.6North America Histology and Cytology Market by Country
      • 9.1.6.1US Histology and Cytology Market
        • 9.1.6.1.1US Histology and Cytology Market by Type of Examination
        • 9.1.6.1.2US Histology and Cytology Market by Product
        • 9.1.6.1.3US Histology and Cytology Market by Test Type
        • 9.1.6.1.4US Histology and Cytology Market by Application
        • 9.1.6.1.5US Histology and Cytology Market by End User
      • 9.1.6.2Canada Histology and Cytology Market
        • 9.1.6.2.1Canada Histology and Cytology Market by Type of Examination
        • 9.1.6.2.2Canada Histology and Cytology Market by Product
        • 9.1.6.2.3Canada Histology and Cytology Market by Test Type
        • 9.1.6.2.4Canada Histology and Cytology Market by Application
        • 9.1.6.2.5Canada Histology and Cytology Market by End User
      • 9.1.6.3Mexico Histology and Cytology Market
        • 9.1.6.3.1Mexico Histology and Cytology Market by Type of Examination
        • 9.1.6.3.2Mexico Histology and Cytology Market by Product
        • 9.1.6.3.3Mexico Histology and Cytology Market by Test Type
        • 9.1.6.3.4Mexico Histology and Cytology Market by Application
        • 9.1.6.3.5Mexico Histology and Cytology Market by End User
      • 9.1.6.4Rest of North America Histology and Cytology Market
        • 9.1.6.4.1Rest of North America Histology and Cytology Market by Type of Examination
        • 9.1.6.4.2Rest of North America Histology and Cytology Market by Product
        • 9.1.6.4.3Rest of North America Histology and Cytology Market by Test Type
        • 9.1.6.4.4Rest of North America Histology and Cytology Market by Application
        • 9.1.6.4.5Rest of North America Histology and Cytology Market by End User
  • 9.2Europe Histology and Cytology Market
    • 9.2.1Europe Histology and Cytology Market by Type of Examination
      • 9.2.1.1Europe Cytology Market by Country
      • 9.2.1.2Europe Histology Market by Country
    • 9.2.2Europe Histology and Cytology Market by Product
      • 9.2.2.1Europe Consumable & Reagents Market by Country
      • 9.2.2.2Europe Instruments & Analysis Software System Market by Country
    • 9.2.3Europe Histology and Cytology Market by Test Type
      • 9.2.3.1Europe Microscopy Methods Market by Country
      • 9.2.3.2Europe Flow Cytometry Market by Country
      • 9.2.3.3Europe Molecular Genetic Methods Market by Country
    • 9.2.4Europe Histology and Cytology Market by Application
      • 9.2.4.1Europe Drug Discovery & Designing Market by Country
      • 9.2.4.2Europe Clinical Diagnostics Market by Country
      • 9.2.4.3Europe Academic Research Market by Country
    • 9.2.5Europe Histology and Cytology Market by End User
      • 9.2.5.1Europe Pharma & Biotech Companies Market by Country
      • 9.2.5.2Europe Diagnostic Laboratories Market by Country
      • 9.2.5.3Europe CDMO Market by Country
      • 9.2.5.4Europe Others Market by Country
    • 9.2.6Europe Histology and Cytology Market by Country
      • 9.2.6.1Germany Histology and Cytology Market
        • 9.2.6.1.1Germany Histology and Cytology Market by Type of Examination
        • 9.2.6.1.2Germany Histology and Cytology Market by Product
        • 9.2.6.1.3Germany Histology and Cytology Market by Test Type
        • 9.2.6.1.4Germany Histology and Cytology Market by Application
        • 9.2.6.1.5Germany Histology and Cytology Market by End User
      • 9.2.6.2UK Histology and Cytology Market
        • 9.2.6.2.1UK Histology and Cytology Market by Type of Examination
        • 9.2.6.2.2UK Histology and Cytology Market by Product
        • 9.2.6.2.3UK Histology and Cytology Market by Test Type
        • 9.2.6.2.4UK Histology and Cytology Market by Application
        • 9.2.6.2.5UK Histology and Cytology Market by End User
      • 9.2.6.3France Histology and Cytology Market
        • 9.2.6.3.1France Histology and Cytology Market by Type of Examination
        • 9.2.6.3.2France Histology and Cytology Market by Product
        • 9.2.6.3.3France Histology and Cytology Market by Test Type
        • 9.2.6.3.4France Histology and Cytology Market by Application
        • 9.2.6.3.5France Histology and Cytology Market by End User
      • 9.2.6.4Russia Histology and Cytology Market
        • 9.2.6.4.1Russia Histology and Cytology Market by Type of Examination
        • 9.2.6.4.2Russia Histology and Cytology Market by Product
        • 9.2.6.4.3Russia Histology and Cytology Market by Test Type
        • 9.2.6.4.4Russia Histology and Cytology Market by Application
        • 9.2.6.4.5Russia Histology and Cytology Market by End User
      • 9.2.6.5Spain Histology and Cytology Market
        • 9.2.6.5.1Spain Histology and Cytology Market by Type of Examination
        • 9.2.6.5.2Spain Histology and Cytology Market by Product
        • 9.2.6.5.3Spain Histology and Cytology Market by Test Type
        • 9.2.6.5.4Spain Histology and Cytology Market by Application
        • 9.2.6.5.5Spain Histology and Cytology Market by End User
      • 9.2.6.6Italy Histology and Cytology Market
        • 9.2.6.6.1Italy Histology and Cytology Market by Type of Examination
        • 9.2.6.6.2Italy Histology and Cytology Market by Product
        • 9.2.6.6.3Italy Histology and Cytology Market by Test Type
        • 9.2.6.6.4Italy Histology and Cytology Market by Application
        • 9.2.6.6.5Italy Histology and Cytology Market by End User
      • 9.2.6.7Rest of Europe Histology and Cytology Market
        • 9.2.6.7.1Rest of Europe Histology and Cytology Market by Type of Examination
        • 9.2.6.7.2Rest of Europe Histology and Cytology Market by Product
        • 9.2.6.7.3Rest of Europe Histology and Cytology Market by Test Type
        • 9.2.6.7.4Rest of Europe Histology and Cytology Market by Application
        • 9.2.6.7.5Rest of Europe Histology and Cytology Market by End User
  • 9.3Asia Pacific Histology and Cytology Market
    • 9.3.1Asia Pacific Histology and Cytology Market by Type of Examination
      • 9.3.1.1Asia Pacific Cytology Market by Country
      • 9.3.1.2Asia Pacific Histology Market by Country
    • 9.3.2Asia Pacific Histology and Cytology Market by Product
      • 9.3.2.1Asia Pacific Consumable & Reagents Market by Country
      • 9.3.2.2Asia Pacific Instruments & Analysis Software System Market by Country
    • 9.3.3Asia Pacific Histology and Cytology Market by Test Type
      • 9.3.3.1Asia Pacific Microscopy Methods Market by Country
      • 9.3.3.2Asia Pacific Flow Cytometry Market by Country
      • 9.3.3.3Asia Pacific Molecular Genetic Methods Market by Country
    • 9.3.4Asia Pacific Histology and Cytology Market by Application
      • 9.3.4.1Asia Pacific Drug Discovery & Designing Market by Country
      • 9.3.4.2Asia Pacific Clinical Diagnostics Market by Country
      • 9.3.4.3Asia Pacific Academic Research Market by Country
    • 9.3.5Asia Pacific Histology and Cytology Market by End User
      • 9.3.5.1Asia Pacific Pharma & Biotech Companies Market by Country
      • 9.3.5.2Asia Pacific Diagnostic Laboratories Market by Country
      • 9.3.5.3Asia Pacific CDMO Market by Country
      • 9.3.5.4Asia Pacific Others Market by Country
    • 9.3.6Asia Pacific Histology and Cytology Market by Country
      • 9.3.6.1China Histology and Cytology Market
        • 9.3.6.1.1China Histology and Cytology Market by Type of Examination
        • 9.3.6.1.2China Histology and Cytology Market by Product
        • 9.3.6.1.3China Histology and Cytology Market by Test Type
        • 9.3.6.1.4China Histology and Cytology Market by Application
        • 9.3.6.1.5China Histology and Cytology Market by End User
      • 9.3.6.2Japan Histology and Cytology Market
        • 9.3.6.2.1Japan Histology and Cytology Market by Type of Examination
        • 9.3.6.2.2Japan Histology and Cytology Market by Product
        • 9.3.6.2.3Japan Histology and Cytology Market by Test Type
        • 9.3.6.2.4Japan Histology and Cytology Market by Application
        • 9.3.6.2.5Japan Histology and Cytology Market by End User
      • 9.3.6.3India Histology and Cytology Market
        • 9.3.6.3.1India Histology and Cytology Market by Type of Examination
        • 9.3.6.3.2India Histology and Cytology Market by Product
        • 9.3.6.3.3India Histology and Cytology Market by Test Type
        • 9.3.6.3.4India Histology and Cytology Market by Application
        • 9.3.6.3.5India Histology and Cytology Market by End User
      • 9.3.6.4South Korea Histology and Cytology Market
        • 9.3.6.4.1South Korea Histology and Cytology Market by Type of Examination
        • 9.3.6.4.2South Korea Histology and Cytology Market by Product
        • 9.3.6.4.3South Korea Histology and Cytology Market by Test Type
        • 9.3.6.4.4South Korea Histology and Cytology Market by Application
        • 9.3.6.4.5South Korea Histology and Cytology Market by End User
      • 9.3.6.5Singapore Histology and Cytology Market
        • 9.3.6.5.1Singapore Histology and Cytology Market by Type of Examination
        • 9.3.6.5.2Singapore Histology and Cytology Market by Product
        • 9.3.6.5.3Singapore Histology and Cytology Market by Test Type
        • 9.3.6.5.4Singapore Histology and Cytology Market by Application
        • 9.3.6.5.5Singapore Histology and Cytology Market by End User
      • 9.3.6.6Malaysia Histology and Cytology Market
        • 9.3.6.6.1Malaysia Histology and Cytology Market by Type of Examination
        • 9.3.6.6.2Malaysia Histology and Cytology Market by Product
        • 9.3.6.6.3Malaysia Histology and Cytology Market by Test Type
        • 9.3.6.6.4Malaysia Histology and Cytology Market by Application
        • 9.3.6.6.5Malaysia Histology and Cytology Market by End User
      • 9.3.6.7Rest of Asia Pacific Histology and Cytology Market
        • 9.3.6.7.1Rest of Asia Pacific Histology and Cytology Market by Type of Examination
        • 9.3.6.7.2Rest of Asia Pacific Histology and Cytology Market by Product
        • 9.3.6.7.3Rest of Asia Pacific Histology and Cytology Market by Test Type
        • 9.3.6.7.4Rest of Asia Pacific Histology and Cytology Market by Application
        • 9.3.6.7.5Rest of Asia Pacific Histology and Cytology Market by End User
  • 9.4LAMEA Histology and Cytology Market
    • 9.4.1LAMEA Histology and Cytology Market by Type of Examination
      • 9.4.1.1LAMEA Cytology Market by Country
      • 9.4.1.2LAMEA Histology Market by Country
    • 9.4.2LAMEA Histology and Cytology Market by Product
      • 9.4.2.1LAMEA Consumable & Reagents Market by Country
      • 9.4.2.2LAMEA Instruments & Analysis Software System Market by Country
    • 9.4.3LAMEA Histology and Cytology Market by Test Type
      • 9.4.3.1LAMEA Microscopy Methods Market by Country
      • 9.4.3.2LAMEA Flow Cytometry Market by Country
      • 9.4.3.3LAMEA Molecular Genetic Methods Market by Country
    • 9.4.4LAMEA Histology and Cytology Market by Application
      • 9.4.4.1LAMEA Drug Discovery & Designing Market by Country
      • 9.4.4.2LAMEA Clinical Diagnostics Market by Country
      • 9.4.4.3LAMEA Academic Research Market by Country
    • 9.4.5LAMEA Histology and Cytology Market by End User
      • 9.4.5.1LAMEA Pharma & Biotech Companies Market by Country
      • 9.4.5.2LAMEA Diagnostic Laboratories Market by Country
      • 9.4.5.3LAMEA CDMO Market by Country
      • 9.4.5.4LAMEA Others Market by Country
    • 9.4.6LAMEA Histology and Cytology Market by Country
      • 9.4.6.1Brazil Histology and Cytology Market
        • 9.4.6.1.1Brazil Histology and Cytology Market by Type of Examination
        • 9.4.6.1.2Brazil Histology and Cytology Market by Product
        • 9.4.6.1.3Brazil Histology and Cytology Market by Test Type
        • 9.4.6.1.4Brazil Histology and Cytology Market by Application
        • 9.4.6.1.5Brazil Histology and Cytology Market by End User
      • 9.4.6.2Argentina Histology and Cytology Market
        • 9.4.6.2.1Argentina Histology and Cytology Market by Type of Examination
        • 9.4.6.2.2Argentina Histology and Cytology Market by Product
        • 9.4.6.2.3Argentina Histology and Cytology Market by Test Type
        • 9.4.6.2.4Argentina Histology and Cytology Market by Application
        • 9.4.6.2.5Argentina Histology and Cytology Market by End User
      • 9.4.6.3UAE Histology and Cytology Market
        • 9.4.6.3.1UAE Histology and Cytology Market by Type of Examination
        • 9.4.6.3.2UAE Histology and Cytology Market by Product
        • 9.4.6.3.3UAE Histology and Cytology Market by Test Type
        • 9.4.6.3.4UAE Histology and Cytology Market by Application
        • 9.4.6.3.5UAE Histology and Cytology Market by End User
      • 9.4.6.4Saudi Arabia Histology and Cytology Market
        • 9.4.6.4.1Saudi Arabia Histology and Cytology Market by Type of Examination
        • 9.4.6.4.2Saudi Arabia Histology and Cytology Market by Product
        • 9.4.6.4.3Saudi Arabia Histology and Cytology Market by Test Type
        • 9.4.6.4.4Saudi Arabia Histology and Cytology Market by Application
        • 9.4.6.4.5Saudi Arabia Histology and Cytology Market by End User
      • 9.4.6.5South Africa Histology and Cytology Market
        • 9.4.6.5.1South Africa Histology and Cytology Market by Type of Examination
        • 9.4.6.5.2South Africa Histology and Cytology Market by Product
        • 9.4.6.5.3South Africa Histology and Cytology Market by Test Type
        • 9.4.6.5.4South Africa Histology and Cytology Market by Application
        • 9.4.6.5.5South Africa Histology and Cytology Market by End User
      • 9.4.6.6Nigeria Histology and Cytology Market
        • 9.4.6.6.1Nigeria Histology and Cytology Market by Type of Examination
        • 9.4.6.6.2Nigeria Histology and Cytology Market by Product
        • 9.4.6.6.3Nigeria Histology and Cytology Market by Test Type
        • 9.4.6.6.4Nigeria Histology and Cytology Market by Application
        • 9.4.6.6.5Nigeria Histology and Cytology Market by End User
      • 9.4.6.7Rest of LAMEA Histology and Cytology Market
        • 9.4.6.7.1Rest of LAMEA Histology and Cytology Market by Type of Examination
        • 9.4.6.7.2Rest of LAMEA Histology and Cytology Market by Product
        • 9.4.6.7.3Rest of LAMEA Histology and Cytology Market by Test Type
        • 9.4.6.7.4Rest of LAMEA Histology and Cytology Market by Application
        • 9.4.6.7.5Rest of LAMEA Histology and Cytology Market by End User

Chapter 10.Company Profiles

  • 10.1Merck KGaA
    • 10.1.1Company Overview
    • 10.1.2Financial Analysis
    • 10.1.3Segmental and Regional Analysis
    • 10.1.4Research & Development Expense
    • 10.1.5SWOT Analysis
  • 10.2Becton, Dickinson, and Company
    • 10.2.1Company Overview
    • 10.2.2Financial Analysis
    • 10.2.3Segmental and Regional Analysis
    • 10.2.4Research & Development Expense
    • 10.2.5Recent strategies and developments:
      • 10.2.5.1Partnerships, Collaborations, and Agreements:
    • 10.2.6SWOT Analysis
  • 10.3Hologic, Inc.
    • 10.3.1Company Overview
    • 10.3.2Financial Analysis
    • 10.3.3Segmental and Regional Analysis
    • 10.3.4Research & Development Expenses
    • 10.3.5SWOT Analysis
  • 10.4Trivitron Healthcare Pvt. Ltd.
    • 10.4.1Company Overview
    • 10.4.2SWOT Analysis
  • 10.5Danaher Corporation
    • 10.5.1Company Overview
    • 10.5.2Financial Analysis
    • 10.5.3Segmental and Regional Analysis
    • 10.5.4Research & Development Expense
    • 10.5.5Recent strategies and developments:
      • 10.5.5.1Partnerships, Collaborations, and Agreements:
    • 10.5.6SWOT Analysis
  • 10.6F. Hoffmann-La Roche Ltd.
    • 10.6.1Company Overview
    • 10.6.2Financial Analysis
    • 10.6.3Segmental and Regional Analysis
    • 10.6.4Research & Development Expense
    • 10.6.5Recent strategies and developments:
      • 10.6.5.1Partnerships, Collaborations, and Agreements:
      • 10.6.5.2Product Launches and Product Expansions:
      • 10.6.5.3Trails and Approvals:
    • 10.6.6SWOT Analysis
  • 10.7Thermo Fisher Scientific, Inc.
    • 10.7.1Company Overview
    • 10.7.2Financial Analysis
    • 10.7.3Segmental and Regional Analysis
    • 10.7.4Research & Development Expenses
    • 10.7.5SWOT Analysis
  • 10.8Koninklijke Philips N.V.
    • 10.8.1Company Overview
    • 10.8.2Financial Analysis
    • 10.8.3Segmental and Regional Analysis
    • 10.8.4Research & Development Expense
    • 10.8.5SWOT Analysis
  • 10.9Sysmex Corporation
    • 10.9.1Company Overview
    • 10.9.2Financial Analysis
    • 10.9.3Regional Analysis
    • 10.9.4Research & Development Expense
    • 10.9.5SWOT Analysis
  • 10.10.Abbott Laboratories
    • 10.10.1Company Overview
    • 10.10.2Financial Analysis
    • 10.10.3Segmental and Regional Analysis
    • 10.10.4Research & Development Expense
    • 10.10.5SWOT Analysis

Chapter 11.Winning imperatives of Histology and Cytology Market

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제